Correlation Between Visa and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Visa and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Visa and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and ArriVent BioPharma,.
Diversification Opportunities for Visa and ArriVent BioPharma,
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Visa and ArriVent is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Visa i.e., Visa and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Visa and ArriVent BioPharma,
Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.34 times more return on investment than ArriVent BioPharma,. However, Visa Class A is 2.9 times less risky than ArriVent BioPharma,. It trades about 0.17 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about 0.05 per unit of risk. If you would invest 27,584 in Visa Class A on August 30, 2024 and sell it today you would earn a total of 3,886 from holding Visa Class A or generate 14.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Visa Class A |
| ArriVent BioPharma, |
Visa and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and ArriVent BioPharma,
The main advantage of trading using opposite Visa and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| ArriVent BioPharma, vs. WiMi Hologram Cloud | ArriVent BioPharma, vs. Anterix | ArriVent BioPharma, vs. NETGEAR | ArriVent BioPharma, vs. The Mosaic |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |